Risk Factors of Early Thyroid Dysfunction After Definitive Radiotherapy in Nasopharyngeal Carcinoma Patients
Overview
Affiliations
Background: To explore the patterns and risk factors of early thyroid dysfunction in nasopharyngeal carcinoma (NPC) patients within 1 year after intensity-modulated radiation therapy (IMRT).
Methods: Patients with NPC who received definitive IMRT between April 2016 and April 2020 were included. All patients had normal thyroid function before definitive IMRT. The chi-square test, Student's T-test, Mann-Whitney U test, Kaplan-Meier method, receiver operating characteristics curve, and Cox proportional hazard analysis were used for statistical analysis.
Results: A total of 132 NPC patients were identified. Of these patients, 56 (42.4%) had hypothyroidism and 17 (12.9%) had hyperthyroidism. The median time to hypothyroidism and hyperthyroidism was 9 months (range, 1-12 months) and 1 month (range, 1-6 months) after definitive IMRT, respectively. In patients with hypothyroidism, 41 (73.2%) had subclinical hypothyroidism and 15 (26.8%) had clinical hypothyroidism. In those with hyperthyroidism, 12 patients (70.6%) had subclinical hyperthyroidism, and five patients (29.4%) had clinical hyperthyroidism. Age, clinical stage, thyroid volume, and V45 were independent risk factors for early radiation-induced hypothyroidism within 1 year after IMRT. Patients aged <47 years, stage III/IV disease, or pre-irradiation thyroid volume < 14 cm had higher risks of developing hypothyroidism.
Conclusion: Primary subclinical hypothyroidism was the most common subtype of early thyroid dysfunction in NPC patients within 1 year after IMRT. Age, clinical stage, thyroid volume, and V45 were independent risk factors for early radiation-induced hypothyroidism in NPC patients.
Lu K, Zhou C, Ren J, Ni J, Yang W, Wang Y Front Public Health. 2025; 12():1526147.
PMID: 39850855 PMC: 11756455. DOI: 10.3389/fpubh.2024.1526147.
Shang K, He Q, Xu X, Luo X, Zhao C, Liu L Ther Clin Risk Manag. 2025; 21():15-25.
PMID: 39802955 PMC: 11721357. DOI: 10.2147/TCRM.S489899.
Huang Y, Chen S, Wang Y, Ou X, Yan H, Gan X Interact J Med Res. 2024; 13:e54891.
PMID: 39361379 PMC: 11487213. DOI: 10.2196/54891.